Bristol Myers Squibb Declares Quarterly Dividend Payment
PRINCETON, N.J., June 17, 2026 Bristol Myers Squibb (BMS) has announced that its Board of Directors has declared a...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
PRINCETON, N.J., June 17, 2026 Bristol Myers Squibb (BMS) has announced that its Board of Directors has declared a...
WATERTOWN, Mass., June 17, 2026 Triveni Bio, a clinical-stage biotechnology company developing innovative antibody therapies for immunological and inflammatory...
